Latest News & Features
Generics
AbbVie and Icelandic biosimilar company Alvotech have settled all US litigation over Alvotech’s proposed generic of AbbVie’s blockbuster arthritis treatment Humira (adalimumab). 10 March 2022
Americas
A subsidiary of Tokyo-based FujiFilm has announced that it has filed a patent infringement lawsuit against ultrasound machine maker Butterfly Network. 10 March 2022
Americas
K&L Gates has hired two life science partners, Hannah Koyfman and David Lu, and their 10-person team to bolster the firm's nascent Boston practice. 10 March 2022
Generics
Mumbai-based pharma company Cipla has filed a lawsuit asking a Delaware court to rule that its proposed generic of Boehringer Ingelheim’s lung disease treatment Ofev does not infringe two patents. 8 March 2022
Big Pharma
Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries. 8 March 2022
Biotechnology
Should the MHLW and CSIMC consider competition in drug pricing, it would be necessary to formulate systems to utilise the expertise of a competition expert, namely the Japan Fair Trade Commission, says Takanori Abe of Abe & Partners. 8 March 2022
Big Pharma
Regeneron has failed to convince a Manhattan district court to drop a lawsuit claiming that it developed COVID-19 treatments using Allele’s fluorescent protein invention without its permission. 7 March 2022
Americas
A seemingly small decision by the US Court of Appeals for the Federal Circuit could have a big impact on owners of design patents, explains Elizabeth Ferrill of Finnegan. 3 March 2022
Americas
The US Chamber of Commerce has warned against the proposed Covid-19 IP waiver, in its latest International IP Index, a report measuring the quality of global IP systems. 3 March 2022
Biotechnology
Harvard College and 10x Genomics have sued Nanostring Technologies, alleging that the company’s CosMx imaging platform infringes two patents covering “gene-mapping” technology. 3 March 2022